Guardant Health
GH
#1571
Rank
NZ$22.79 B
Marketcap
NZ$175.52
Share price
0.68%
Change (1 day)
191.39%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company